NeoPhore Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
NeoPhore Ltd. - overview
Established
2017
Location
Cheshire, -, UK
Primary Industry
Biotechnology
About
Based in Cheshire, UK, and founded in 2017, NeoPhore Ltd. operates as a biotechnology company that develops small-molecule therapies. The company was founded by Alberto Bardelli. In April 2024, NeoPhore Ltd.
raised GBP 5. 02 million of Series B funding from Bristol-Myers Squibb Company. The Series B round of financing values NeoPhore Ltd. at GBP 56.
10 million post-money. As of 2024, the company is led by its CEO, Matthew Baker. NeoPhore offers novel small-molecule immuno-oncology therapeutics. The company develops small-molecule drugs to treat cancer.
The company plans to use the funds raised in April 2024 to further research its deoxyribonucleic acid mismatch repair pathway and accelerate the progression of its pre-clinical studies.
Current Investors
Sixth Element Capital, Innovate UK, Astellas Venture Management
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Oncology/Cancer Treatment, Pharmaceutical Research & Development
Website
www.neophore.com
Verticals
Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only
NeoPhore Ltd. - financials
| Fiscal Year Ended | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | Mar 31, 2025 |
|---|---|---|---|---|
| Revenue (USD) | - | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - |
| EBITDA (USD) | - | - | - | - |
| Operating Income (USD) | - | - | - | - |
| Operating Margin | - | - | - | - |
| % EBITDA Margin | - | - | - | - |
| NET Income (USD) | (4,865,761) | - | - | - |
| % Net Margin | - | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.